Alot of positives to take from this guys, I think people are jumping to conclusions way too fast here, I'll break down why:
Here's the link to the official results release: https://www.samumed.com/files/2016/S...nal_3-1-16.pdf
1. This was a 90 day once-a-day trial, then 45 days of post-treatment assesment, meaning they used the drug for a very short period of time. After stopping treatment, the hair count continued to increase at month 4-5 (histogen claimed the same thing and after a year had a significant increase)
2. It shows clear efficacy on hair, and should really see how an increased dose affects the hair over the course of a year
3. We're guarenteed at least a phase IIb here, and I would hope they do once a day for an entire year and see how it is, as well as follow up with the previous group post-treatment after a year and see if they maintained, increased or lost in hair count.
4. The adverse events or side effects were very minor, mostly just tooth ache or muscle ache, nothing major as you can see in the slides above (and only about 5-10% of the subjects in the drug portion of the trial felt the affects).
very very promising stuff, clearly on to something with this drug, I think the hope has to be that it continues to work as more time passes(which appears to be the case).
hopefully they begin Phase IIb or Phase III right away.
Here's the link to the official results release: https://www.samumed.com/files/2016/S...nal_3-1-16.pdf
1. This was a 90 day once-a-day trial, then 45 days of post-treatment assesment, meaning they used the drug for a very short period of time. After stopping treatment, the hair count continued to increase at month 4-5 (histogen claimed the same thing and after a year had a significant increase)
2. It shows clear efficacy on hair, and should really see how an increased dose affects the hair over the course of a year
3. We're guarenteed at least a phase IIb here, and I would hope they do once a day for an entire year and see how it is, as well as follow up with the previous group post-treatment after a year and see if they maintained, increased or lost in hair count.
4. The adverse events or side effects were very minor, mostly just tooth ache or muscle ache, nothing major as you can see in the slides above (and only about 5-10% of the subjects in the drug portion of the trial felt the affects).
very very promising stuff, clearly on to something with this drug, I think the hope has to be that it continues to work as more time passes(which appears to be the case).
hopefully they begin Phase IIb or Phase III right away.
Comment